Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 655950Generated: October 29, 2026

N-(tert-butoxycarbonyl)glycine → (1-(2-(Tert-butoxycarbonyl)aminoacetyl)-4-(2-chlorobenzylcarbamoyl)piperidin-4-yl)methyl 4-ethylphenylcarbamate

https://huagongshe.com/reaction/655950

Reaction equation

Participants

RoleNameHCIDCharge
ReactantN-(tert-butoxycarbonyl)glycineHCID 78288—
ReactantDiisopropylethylamineHCID 81531—
ReactantMethanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 9886157—
Reactant(4-(2-Chlorobenzylcarbamoyl)piperidin-4-yl)methyl 4-ethylphenylcarbamate hydrochlorideHCID 69162882—
SolventDimethylformamideHCID 6228—
Product(1-(2-(Tert-butoxycarbonyl)aminoacetyl)-4-(2-chlorobenzylcarbamoyl)piperidin-4-yl)methyl 4-ethylphenylcarbamateHCID 5977852884%

Reaction Steps

To a solution of Boc-Gly-OH (54 mg, 0.31 mmol, 1.2 equiv.) in DMF (1 mL) were added HATU (120 mg, 0.31 mmol, 1.2 equiv.), followed by addition of (4-(2-chlorobenzylcarbamoyl)piperidin-4-yl)methyl 4-ethylphenylcarbamate hydrochloride (120 mg, 0.26 mmol, 1 equiv.) and DIEA (89 μL, 0.51 mmol, 2 equiv.) at rt The reaction mixture was stirred for 3 h and purified on RP-HPLC using a mixture of acetonitrile and H2O to give (1-(2-(tert-butoxycarbonyl)aminoacetyl)-4-(2-chlorobenzylcarbamoyl)piperidin-4-yl)methyl 4-ethylphenylcarbamate (127 mg, 84%). LRMS (M-Boc+H+) m/z 487.1.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08071625B2
Source datasetuspto-grants-2011_12
ORD IDord-5d6d17be7e3946719bec7d15ae4fa003
Source noteuspto-grants-2011_12